Thomas Willemsen, Tessa Therapeutics CEO
August 22, 2022 06:51 AM EDTUpdated 10:39 AM
People

Flush with $126M raise, Tes­sa Ther­a­peu­tics woos new CEO from Take­da

Amber Tong

Af­ter some repo­si­tion­ing — and a $126 mil­lion fi­nanc­ing round to take it down that di­rec­tion — Sin­ga­pore’s Tes­sa Ther­a­peu­tics has found a new cap­tain to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J takes 340B fight with fed­er­al gov­ern­ment to court

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times